The Valley Desk

NCT05309668 · Interventional trial

Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to <7 Years With NF1-related Symptomatic, Inoperable PN

Overall registry status Active not recruiting

Phase 1 · Phase 2

Conditions Neurofibromatosis Type 1

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov